Autori: Laguna P
| Naslov | Prior Treatment Regimen Influences Annualised Bleeding Rate During Long- Term Prophylaxis With Turoctocog Alfa: Experiences From Multinational Trials (Meeting Abstract) |
| Autori | Laguna P Savic Aleksandar D  Matytsina Irina Zeuthen N
|
| Info | HAEMOPHILIA, (2015), vol. 21 br. , Suppl. 2, str. 49-49 |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
     |
| Naslov | Results from a large multinational clinical trial (guardian (TM) 3) using prophylactic treatment with turoctocog alfa in paediatric patients with severe haemophilia A: safety, efficacy and pharmacokinetics (Article) |
| Autori | Kulkarni R Karim Abdul F Glamocanin S Janic Dragana M Vdovin V Ozelo M Rageliene L Carboni E Laguna P Dobaczewski G Seremetis S Lindblom A Santagostino E
|
| Info | HAEMOPHILIA, (2013), vol. 19 br. 5, str. 698-705 |
| Projekat | Novo Nordisk A/S (Bagsvaerd, Denmark) |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
| Naslov | Safety and efficacy of turoctocog alfa in the prevention and treatment of bleeding episodes in paediatric patients with severe haemophilia A and below 12 years of age (Meeting Abstract) |
| Autori | Kulkarni R Karim Abdul F Glamocanin S Janic Dragana M Vdovin V Ozelo M Rageliene L Carboni E Laguna P Dobaczewski G Santagostino E
|
| Info | HAEMOPHILIA, (2012), vol. 18 br. 5, str. 829-829 |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Clinical efficacy, safety and pharmacokinetic properties of the plasma-derived factor IX concentrate Haemonine (R) in previously treated patients with severe haemophilia B (Article) |
| Autori | Serban M Skotnicki AB Colovic Milica D Jinca C Klukowska A Laguna P Wolf DM |
| Info | HAEMOPHILIA, (2012), vol. 18 br. 2, str. 175-181 |
| Projekat | Biotest AG, Dreieich, Germany; Biotest AG |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
